Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Premature Ejaculation: early-phase trial registry

1 of 2 indexed Premature Ejaculation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Premature Ejaculation: 2 US clinical trials tracked, 1 recruiting.

Premature Ejaculation is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Ixchelsis Limited, running 1 of these trials.

Enrollment posture brief

Registry condition premature-ejaculation

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Premature Ejaculation (this)50%
Open-enrollment share among volume-matched conditions near Premature Ejaculation

Premature Ejaculation lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Premature Ejaculation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Premature Ejaculation is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Premature Ejaculation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

IX-01 1200 mg Drug
1 trials
IX-01 800 mg Drug
1 trials
IX-01 400 mg Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Premature Ejaculation trials. A trial with sites in several states counts in each.

Utah 1 trials
Ohio 1 trials
New York 1 trials
Nevada 1 trials
Missouri 1 trials
Massachusetts 1 trials
Georgia 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Premature Ejaculation page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Premature Ejaculation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Ixchelsis Limited sponsors the most Premature Ejaculation trials on record, review their full trial history before evaluating a specific study. See Ixchelsis Limited's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Premature Ejaculation condition card totals 2 registered trials; most-linked intervention IX-01 1200 mg; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.